{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:03:13Z","timestamp":1790960593760,"version":"4.1.0"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T00:00:00Z","timestamp":1546214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Bari Medical School"},{"name":"Agenzia Regionale per la Tecnologia e l'Innovazione (ARTI) Puglia"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0210023","type":"journal-article","created":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T18:42:39Z","timestamp":1546281759000},"page":"e0210023","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Anti-carbamylated protein antibodies and skin involvement in patients with systemic sclerosis: An intriguing association"],"prefix":"10.1371","volume":"13","author":[{"given":"Elvira","family":"Favoino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella","family":"Prete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5617-9829","authenticated-orcid":true,"given":"Serena","family":"Vettori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Addolorata","family":"Corrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Paolo","family":"Cantatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7852-9137","authenticated-orcid":true,"given":"Gabriele","family":"Valentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4072-4244","authenticated-orcid":true,"given":"Federico","family":"Perosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,12,31]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.semarthrit.2007.10.010","article-title":"The immunobiology of systemic sclerosis","volume":"38","author":"YS Gu","year":"2008","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","article-title":"Systemic sclerosis: a prototypic multisystem fibrotic disorder","volume":"117","author":"J Varga","year":"2007","journal-title":"J Clin Invest"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fimmu.2015.00167","article-title":"Autoantibodies in systemic sclerosis: unanswered questions","volume":"6","author":"C Kayser","year":"2015","journal-title":"Front Immunol"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/art.11113","article-title":"Evidence-based guidelines for the use of immunologic tests: anticentromere, Scl-70, and nucleolar antibodies","volume":"49","author":"JD Reveille","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"25","key":"ref5","doi-asserted-by":"crossref","first-page":"e3931","DOI":"10.1097\/MD.0000000000003931","article-title":"Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease","volume":"95","author":"F Perosa","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1172\/JCI118377","article-title":"IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. Induction of adhesion molecule expression and involvement of endothelium-derived cytokines","volume":"97","author":"D Carvalho","year":"1996","journal-title":"J Clin Invest"},{"issue":"3","key":"ref7","first-page":"450","article-title":"Measurement and characterisation of circulating anti-endothelial cell IgG in connective tissue diseases","volume":"72","author":"J Rosenbaum","year":"1988","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0002-9343(96)00404-4","article-title":"Antiendothelial cell antibodies: useful markers of systemic sclerosis","volume":"102","author":"KV Salojin","year":"1997","journal-title":"Am J Med"},{"issue":"1","key":"ref9","first-page":"9","article-title":"Autoantibodies to fibroblasts in scleroderma","volume":"8","author":"TJ Brentnall","year":"1982","journal-title":"J Clin Lab Immunol"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/art.10361","article-title":"Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis","volume":"46","author":"C Chizzolini","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/ar4457","article-title":"Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis","volume":"16","author":"A Kill","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1365-2249.1996.d01-867.x","article-title":"Antibodies to membranes of endothelial cells and fibroblasts in scleroderma","volume":"106","author":"MB Hill","year":"1996","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"ref13","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1002\/art.24049","article-title":"Antifibroblast antibodies in systemic sclerosis induce fibroblasts to produce profibrotic chemokines, with partial exploitation of toll-like receptor 4","volume":"58","author":"S Fineschi","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.coi.2007.11.004","article-title":"Pathogenic autoantibodies in systemic sclerosis","volume":"19","author":"A Gabrielli","year":"2007","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/0394632015572750","article-title":"From microvasculature to fibroblasts: Contribution of anti-endothelial cell antibodies in systemic sclerosis","volume":"28","author":"C Corallo","year":"2015","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/ard.2010.135772","article-title":"Involvement of functional autoantibodies against vascular receptors in systemic sclerosis","volume":"70","author":"G Riemekasten","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/ar4458","article-title":"How citrullination invaded rheumatoid arthritis research","volume":"16","author":"WJ van Venrooij","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"ref18","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1373\/clinchem.2011.163188","article-title":"Carbamylation-derived products: bioactive compounds and potential biomarkers in chronic renal failure and atherosclerosis","volume":"57","author":"S Jaisson","year":"2011","journal-title":"Clin Chem"},{"issue":"42","key":"ref19","doi-asserted-by":"crossref","first-page":"17372","DOI":"10.1073\/pnas.1114465108","article-title":"Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage","volume":"108","author":"J Shi","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.autrev.2013.10.008","article-title":"Carbamylation and antibodies against carbamylated proteins in autoimmunity and other pathologies","volume":"13","author":"J Shi","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s13075-016-1173-0","article-title":"Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases","volume":"18","author":"A Pecani","year":"2016","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1053\/j.ajkd.2014.04.034","article-title":"Protein carbamylation in kidney disease: pathogenesis and clinical implications","volume":"64","author":"S Kalim","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"ref23","first-page":"1","article-title":"Structure and metabolism of arterial elastin","volume":"17","author":"RB Rucker","year":"1977","journal-title":"Int Rev Exp Pathol"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.chembiol.2005.11.005","article-title":"Impact of carbamylation on type I collagen conformational structure and its ability to activate human polymorphonuclear neutrophils","volume":"13","author":"S Jaisson","year":"2006","journal-title":"Chem Biol"},{"key":"ref25","article-title":"Carbamylated albumin is one of the target antigens of anti-carbamylated protein antibodies","author":"S Nakabo","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"14","key":"ref26","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJM198104023041406","article-title":"Hemoglobin carbamylation in uremia","volume":"304","author":"R Fluckiger","year":"1981","journal-title":"N Engl J Med"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/ki.1992.179","article-title":"Carbamylation-induced alterations in low-density lipoprotein metabolism","volume":"41","author":"S Horkko","year":"1992","journal-title":"Kidney Int"},{"issue":"7","key":"ref28","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/art.40098","article-title":"Brief Report: Anti-Carbamylated Protein Antibodies in Rheumatoid Arthritis Patients Are Reactive With Specific Epitopes of the Human Fibrinogen beta-Chain","volume":"69","author":"JD Jones","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jaut.2017.02.008","article-title":"Identification of carbamylated alpha 1 anti-trypsin (A1AT) as an antigenic target of anti-CarP antibodies in patients with rheumatoid arthritis","volume":"80","author":"MK Verheul","year":"2017","journal-title":"J Autoimmun"},{"issue":"9","key":"ref30","article-title":"Increased Serum Levels of Anti-Carbamylated 78-kDa Glucose-Regulated Protein Antibody in Patients with Rheumatoid Arthritis","volume":"17","author":"HC Yu","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13075-016-1001-6","article-title":"Antibodies to carbamylated alpha-enolase epitopes in rheumatoid arthritis also bind citrullinated epitopes and are largely indistinct from anti-citrullinated protein antibodies","volume":"18","author":"E Reed","year":"2016","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"ref32","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00296-016-3472-9","article-title":"Carbamylated vimentin represents a relevant autoantigen in Latin American (Cuban) rheumatoid arthritis patients","volume":"36","author":"G Martinez","year":"2016","journal-title":"Rheumatol Int"},{"issue":"1","key":"ref33","first-page":"47","article-title":"From Thibierge-Weissenbach syndrome (1910) to anti-centromere antibodies (1980). Clinical and biological features of scleroderma","volume":"150","author":"O Meyer","year":"1999","journal-title":"Ann Med Interne (Paris)"},{"issue":"11","key":"ref34","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"HF van den","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"2","key":"ref35","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"EC LeRoy","year":"1988","journal-title":"J Rheumatol"},{"issue":"3","key":"ref36","first-page":"S42","article-title":",","volume":"21","author":"TA Medsger Jr.","year":"2003","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"ref37","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1136\/ard.2006.066530","article-title":"The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosis","volume":"66","author":"L Czirjak","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"ref38","doi-asserted-by":"crossref","first-page":"e61453","DOI":"10.1371\/journal.pone.0061453","article-title":"Autoantibodies recognizing the amino terminal 1\u201317 segment of CENP-A display unique specificities in systemic sclerosis","volume":"8","author":"E Favoino","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/annrheumdis-2012-201559","article-title":"Recognition of citrullinated and carbamylated proteins by human antibodies: specificity, cross-reactivity and the 'AMC-Senshu' method","volume":"72","author":"J Shi","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"ref40","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3899\/jrheum.150179","article-title":"Anti-carbamylated Protein Antibody Levels Correlate with Anti-Sa (Citrullinated Vimentin) Antibody Levels in Rheumatoid Arthritis","volume":"43","author":"GJ Challener","year":"2016","journal-title":"J Rheumatol"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13075-017-1324-y","article-title":"The prevalence of ACPA is lower in rheumatoid arthritis patients with an older age of onset but the composition of the ACPA response appears identical","volume":"19","author":"DM Boeters","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s13075-016-1192-x","article-title":"Antibodies against carbamylated proteins and cyclic citrullinated peptides in systemic lupus erythematosus: results from two well-defined European cohorts","volume":"18","author":"M Ziegelasch","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"ref43","first-page":"961203317713141","article-title":"Anti-carbamylated protein antibodies in systemic lupus erythematosus patients with articular involvement","author":"L Massaro","year":"2017","journal-title":"Lupus"},{"issue":"8","key":"ref44","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1136\/annrheumdis-2015-207751","article-title":"Antibodies against carbamylated proteins are present in primary Sjogren's syndrome and are associated with disease severity","volume":"75","author":"B Bergum","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"ref45","doi-asserted-by":"crossref","first-page":"e0161141","DOI":"10.1371\/journal.pone.0161141","article-title":"Anti-Carbamylated Protein Antibodies as a Reproducible Independent Type of Rheumatoid Arthritis Autoantibodies","volume":"11","author":"A Montes","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"ref46","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5114\/reum.2017.66680","article-title":"Assessment of anti-CarP antibodies, disease activity and quality of life in rheumatoid arthritis patients on conventional and biological disease-modifying antirheumatic drugs","volume":"55","author":"S Kumar","year":"2017","journal-title":"Reumatologia"},{"issue":"1\u20132","key":"ref47","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12026-014-8560-x","article-title":"Anti-CarP antibodies as promising marker to measure joint damage and disease activity in patients with rheumatoid arthritis","volume":"61","author":"A Yee","year":"2015","journal-title":"Immunol Res"},{"issue":"4","key":"ref48","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/art.37830","article-title":"Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis","volume":"65","author":"J Shi","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"5","key":"ref49","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1073\/pnas.1517096113","article-title":"Protein carbamylation is a hallmark of aging","volume":"113","author":"L Gorisse","year":"2016","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0210023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T15:54:47Z","timestamp":1694534087000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0210023"}},"subtitle":[],"editor":[{"given":"Valerio","family":"De Vita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,12,31]]},"references-count":49,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0210023","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,31]]}}}